The folding mechanism and key metastable state identification of the PrP127–147 monomer studied by molecular dynamics simulations and Markov state model analysis

文献情報

出版日 2017-04-03
DOI 10.1039/C7CP01521F
インパクトファクター 3.676
著者

Shuangyan Zhou, Qianqian Wang, Yuwei Wang, Wei Han, Huanxiang Liu


原文を見る

要旨

The structural transition of prion proteins from a native α-helix (PrPC) to a misfolded β-sheet-rich conformation (PrPSc) is believed to be the main cause of a number of prion diseases in humans and animals. Understanding the molecular basis of misfolding and aggregation of prion proteins will be valuable for unveiling the etiology of prion diseases. However, due to the limitation of conventional experimental techniques and the heterogeneous property of oligomers, little is known about the molecular architecture of misfolded PrPSc and the mechanism of structural transition from PrPC to PrPSc. The prion fragment 127–147 (PrP127–147) has been reported to be a critical region for PrPSc formation in Gerstmann–Straussler–Scheinker (GSS) syndrome and thus has been used as a model for the study of prion aggregation. In the present study, we employ molecular dynamics (MD) simulation techniques to study the conformational change of this fragment that could be relevant to the PrPC–PrPSc transition. Employing extensive replica exchange molecular dynamics (REMD) and conventional MD simulations, we sample a huge number of conformations of PrP127–147. Using the Markov state model (MSM), we identify the metastable conformational states of this fragment and the kinetic network of transitions between the states. The resulting MSM reveals that disordered random-coiled conformations are the dominant structures. A key metastable folded state with typical extended β-sheet structures is identified with Pro137 being located in a turn region, consistent with a previous experimental report. Conformational analysis reveals that intrapeptide hydrophobic interaction and two key residue interactions, including Arg136–His140 and Pro137–His140, contribute a lot to the formation of ordered extended β-sheet states. However, network pathway analysis from the most populated disordered state indicates that the formation of extended β-sheet states is quite slow (at the millisecond level), as large structural rearrangement is needed from disordered states. We speculate that the formation process of the extended β-sheet folded states may represent an important event during the early formation of prion oligomers and the results of our study provide insights into the molecular details of the early stage of prion aggregation.

関連文献

A facile strategy to fabricate a skin-like hydrogel with adhesive and highly stretchable attributes through small molecule triggering toward flexible electronics

Qi Chen, Xiang Ke, Yusong Cai, Hao Wang, Zhiyun Dong, Xinlong Li, Jinlin Li, Xinyuan Xu, Jun Luo

2023-11-15 Communication

DOI: 10.1039/D3TB02186F

Front cover

2023-12-18 Cover

DOI: 10.1039/D4NJ90001D

Simple devising of N-doped carbon dots (N-CDs) as a low-cost probe for selective environmental toxin detection and security applications

Kumaresan Annamalai, Arun Annamalai, Ramya Ravichandran, Anandhavalli Jeevarathinam, Padmanaban Annamalai, Hector Valdes, Sundaravadivel Elumalai

2023-11-17 Paper

DOI: 10.1039/D3NJ04571D

Calixarene-based cryoprotectants for ice recrystallization inhibition and cell cryopreservation

Bing Hu, Juan-Juan Li, Yan-Bin Ren, Tian-Xing Zhang, Li-Bin Chen, Xiao-Liu Li, Ke-Rang Wang

2023-11-20 Communication

DOI: 10.1039/D3TB02432F

Advancement in total hip implant: a comprehensive review of mechanics and performance parameters across diverse novelties

Md Mohiuddin Soliman, Mohammad Tariqul Islam, Muhammad E. H. Chowdhury, Farayi Musharavati, Touhidul Alam, Norbahiah Misran, Sakib Mahmud, Amith Khandakar

2023-10-11 Review Article

DOI: 10.1039/D3TB01469J

Metal–organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field

Wei Cao, Zezhi Lin, Daoyi Zheng, Jianjun Zhang, Weili Heng, Yuanfeng Wei, Yuan Gao, Shuai Qian

2023-10-20 Review Article

DOI: 10.1039/D3TB01612A

Optimal synthesis conditions for NBF-modified 8,13-dihydroberberine derivatives

A. D. Zagrebaev, V. V. Butova, A. A. Guda, S. V. Chapek, O. N. Burov, S. V. Kurbatov, E. Yu. Vinyukova, M. E. Neganova, Yu. R. Aleksandrova, N. S. Nikolaeva, O. P. Demidov, A. V. Soldatov

2023-12-05 Paper

DOI: 10.1039/D3NJ04562E

Back cover

2023-12-13 Cover

DOI: 10.1039/D3TB90233A

Physically cross-linked organo-hydrogels for friction interfaces in joint replacements: design, evaluation and potential clinical applications

Zheng Li, Jia Wan, Wanbo Zhu, Yingjie Wang, Yuan Chen, Baoliang Lu, Junchen Zhu, Chen Zhu, Xianzuo Zhang

2023-11-16 Paper

DOI: 10.1039/D3TB01830J

Back cover

2023-11-22 Cover

DOI: 10.1039/D3TB90221H

こちらもおすすめ

化合物よくある質問

3-(2-オキサプロピル)ベンzoic酸はどのように合成されますか?

3-(2-オキサプロピル)ベンzoic酸は、ベンzoic酸とプロパノ酸をヒドロキシム化合物として反応させて生成します。具体的には、ベンzoic酸とプロパノ酸を反...

205927-63-53-(2-Oxopropyl)benzo...
化合物よくある質問

BOC-L-3-氟苯丙氨酸の主な用途は何ですか?

BOC-L-3-フローユーノリファンリンは、合成化学や薬品開発のための保護基として広く使用されています。

114873-01-73-Fluoro-N-{[(2-meth...
化合物よくある質問

4-メチル-4-ピペリジニル-1-ピロリドイン甲酸の主な用途は何ですか?

4-メチル-4-ピペリジニル-1-ピロリドイン甲酸は、主に医薬品の合成材料や研究用物質として使用されます。さらに、一部の薬理学的研究にも応用されています。

885523-47-7(4-Methyl-4-piperidi...
化合物よくある質問

Biotin-PEG3-oxyamine HCl塩について、適切な化合物名称に適用される法規ガイドラインは何ですか?

Biotin-PEG3-oxyamine HCl塩は、GHS( Globally Harmonized System of Classification and...

1786206-22-1Biotin-PEG3-oxyamine...
化合物よくある質問

N-(4-イソチオシアネートフェニル)-2-メトキシアリニンはどのように合成されますか?

N-(4-イソチオシアネートフェニル)-2-メトキシアリニンは、4-イソチオシアノフェノールと2-メトキシアリニルアミンのアミニド反応を用いて合成されます。この...

915919-57-2N-(4-Isothiocyanatop...
化合物よくある質問

金粉蕨亭2'-O-葡萄糖甙の主な用途は何ですか?

金粉蕨亭2'-O-葡萄糖甙は主に薬理研究や医薬品製造に使用され、抗炎症作用や抗がん作用などがあります。また、その構造や性質から、合成化学や化学生理学の研究にも用...

76947-60-92-(7-Hydroxy-2,2,4,6...
化合物よくある質問

2-(2-ニトロフェニル)酢酸ヒドライドの物理化学的性質は何ですか?

2-(2-ニトロフェニル)酢酸ヒドライドのCAS番号は114953-81-0です。この化合物は白色結晶性粉末で、分子量は244.12です。水溶性は限られており、...

114953-81-02-(2-Nitrophenyl)ace...
化合物よくある質問

5-(ヒドロキシメチル)-2-チオキソ-2,3-ジヒドロピリミジン-4(1H)-オンを取り扱う際の実験室安全事項は何ですか?

この化合物は高活性のため、取り扱いには注意が必要です。PPE(個人保護具)としてゴーグル、ガントリー、および防滴シールドを着用することが推奨されます。ドラフトチ...

93185-31-05-(Hydroxymethyl)-2-...
化合物よくある質問

11-脱氢血栓烷 b2の市場動向や研究トレンドはどうですか?

11-脱氢血栓烷 b2は、血栓溶解・抗凝固作用に関する研究で注目を集めています。特に心血管疾患の治療法開発において、市場の需要が高まっています。研究トレンドとし...

67910-12-77-{(2R,3S,4S)-4-Hydr...
化合物よくある質問

3,3-二甲基哌啶-4-酮はどのように保存すればよいですか?

3,3-二甲基哌啶-4-酮は避光、常温、乾燥した場所で保存してください。容器は密閉し、遠くから火源を離して保管することを確認してください。

150668-82-93,3-Dimethyl-4-piper...

掲載誌

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
自己引用率: 10.3%
年間論文数: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

おすすめサプライヤー

免責事項
このページに表示される学術雑誌情報は、参考および研究目的のみを目的としています。当社は雑誌出版社とは提携しておらず、投稿の取り扱いも行っておりません。出版に関するお問い合わせは、各雑誌出版社に直接ご連絡ください。
表示されている情報に誤りがある場合は、support@chemtradehub.com までご連絡ください。迅速に確認し、対応いたします。